Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Neurocrine Biosciences Inc., 3 years.
Neurocrine Biosciences Inc.
Director
Biogen Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2026 | Biogen Inc. | Grant or award | +1,505 | — | — |
| Jun 5, 2026 | Neurocrine Biosciences Inc. | Option exercise | +15,000 | $53.64 | $804,600 |
| Jun 5, 2026 | Neurocrine Biosciences Inc. | Option exercise | +10,000 | $79.79 | $797,900 |
| Jun 5, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −7,883 | $163.81 | $1,291,314 |
| Jun 5, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −2,549 | $164.44 | $419,158 |
| Jun 5, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −6,896 | $165.79 | $1,143,288 |
| Jun 5, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −5,829 | $166.56 | $970,878 |
| Jun 5, 2026 | Neurocrine Biosciences Inc. | Open-market sale | −1,843 | $167.31 | $308,352 |
| May 21, 2026 | Neurocrine Biosciences Inc. | Option exercise | +3,318 | — | — |
| Sep 2, 2025 | Neurocrine Biosciences Inc. | Gift | −1,000 | — | — |
| Jun 17, 2025 | Biogen Inc. | Grant or award | +2,370 | — | — |
| May 22, 2025 | Neurocrine Biosciences Inc. | Option exercise | +2,869 | — | — |
| Mar 7, 2025 | Biogen Inc. | Open-market sale | −8,760 | $150.02 | $1,314,175 |
| Feb 13, 2025 | Neurocrine Biosciences Inc. | Open-market sale | −13,831 | $116.69 | $1,613,939 |
| Nov 4, 2024 | Neurocrine Biosciences Inc. | Gift | −2,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.